您现在的位置是:【微信950216】新金宝公司电话 > 休闲
Weight regain happens 4x faster after stopping GLP
【微信950216】新金宝公司电话2026-02-01 02:31:48【休闲】7人已围观
简介Facebook TwitterThreads FlipboardCommentsPrintEmailAdd Fox News on GoogleWeigh
- Threads
- Comments
- Add Fox News on Google
Weight-loss journeys can cause social strains for GLP-1 patients, doctor says
Dr. Rocio Salas-Whalen shares how rapid GLP-1–driven weight reductions leave many individuals confronting psychological challenges that complicate relationships and social routines.
NEWYou can now listen to Fox News articles!Discontinuing the use of GLP-1 weight-loss medications triggers weight regain more than previously thought, a new study suggested.
The research, which was published in The BMJ, found that stopping the drugs is also associated with a reversal of improvements in heart and metabolic health, including cholesterol and blood pressure.
University of Oxford researchers analyzed 37 studies published up to February 2025, involving more than 9,000 participants who had undergone an average of 39 weeks of weight-loss treatment.
OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT LOSS DRUGS FOR 4 KEY REASONS
On average, patients regained about 0.9 pounds per month after stopping treatment. Researchers estimated that body weight and risk markers for diabetes and heart disease would return to pre-treatment levels in less than two years.

On average, patients regained about 0.9 pounds per month after stopping treatment. (iStock)
The analysis also revealed that the weight came back on nearly four times faster than after changing or quitting a diet or exercise regimen, no matter how many pounds had been shed.
OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU
"The evidence suggests that despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long-term weight control," the researchers commented in a press release.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The study authors acknowledged that only eight studies assessed treatment with newer GLP-1 drugs, at a maximum follow-up period of 12 months after the medication was stopped. This could serve as a limitation, although three additional methods of analysis provided similar results.

These findings question the effectiveness of GLP-1s for long-term weight loss, the researchers noted. (iStock)
In an editorial responding to the study, Dr. Qi Sun, associate professor of medicine at Brigham and Women’s Hospital and Harvard Medical School, wrote that these findings "cast doubt" on the idea that GLP-1s are a "perfect cure for obesity."
CLICK HERE FOR MORE HEALTH STORIES
"People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications," he said. "Healthy dietary and lifestyle practices should remain the foundation for obesity treatment and management, with medications such as GLP-1 receptor agonists used as adjuncts."
"Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care."
很赞哦!(89)
相关文章
- 中国古代名人故事:古代名人王献之
- 《粒子之心》PC版下载 Steam正版分流下载
- 山西:特色专业镇为高质量发展注入新动能
- Tượng ngựa 'vàng chói' được đấu giá 70 triệu đồng: Câu chuyện ấm lòng phía sau
- 俄罗斯总统普京会见伊朗最高领袖顾问拉里贾尼
- กาซา: ชั้นเรียนของเด็ก ๆ ในกาซากลับมาเปิดสอนอีกครั้งในเต็นท์ชั่วคราว ท่ามกลางซากปรักหักพัง
- 厨余垃圾投绿桶 分类处理环境美
- 【聚焦2023年山西省第九次旅游发展大会】畅游三晋大地 感悟中华文化
- 美国州际公路坍塌事故被升级为危险品事件
- 詹姆斯·卡梅隆再创影史第一!四部电影票房均破十亿美元
热门文章
站长推荐
友情链接
- [新浪彩票]足彩25188期冷热指数:曼联压制抢分
- 《缘分来了就是你(广场舞)》(曹越&门丽演唱)的文本歌词及LRC歌词
- 潮汐守望者兑换码2024最新汇总 通用礼包兑换码推荐
- 追梦辱骂科尔再造内乱 但这次他却把自己逼入死角?
- 胜利女神妮姬2周年直播兑换码在哪里 2周年直播兑换码最新2024一览
- 宝山高境:探索参与式社区规划,聚智赋能社区治理
- “人类高质量”回合游戏?带妹骑条鱼去打架,蜀境传说真的好玩吗?
- 固液分离环保分类垃圾桶 小学生发明让环境更美丽
- 因发生交通事故构成犯罪 这14人终生禁驾!
- 英雄联盟s14全球总决赛参赛队伍有哪些 LPLs14全球总决赛中国队名单一览
- 烤漆垃圾桶的工艺与优点
- 会计学专业开题报告范文
- 小桶大爱:三色双分垃圾桶上的文明印记
- “物之语”亮相中国美术馆 探索绘材与绘画语言的互动关系
- 山东男篮官宣签约2米12外援 多次入选英国国家队
- 杨梅酒的做法及功效
- aespa成员Giselle与RIIZE成员Shotaro传恋情?粉丝调查指“证据存疑”
- 蚂蚁集团CEO韩歆毅:阿福三、四、五线用户占比55%,三分之一是中老年用户
- 钟南山院士谈AI:AI不是取代医生,而是为老百姓解决看病贵看病难的问题
- CEO Trương Minh Tuấn đưa HVN Travel vươn tầm du lịch Dubai, Nhật Bản






